TAPRIZOSIN
UNII EQ8YV2D86Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Taprizosin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EQ8YV2D86Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 210538-44-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

EQ8YV2D86Y

CAS Registry Number

210538-44-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TAPRIZOSIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H26N6O4S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OLYXPBZBZBVRGD-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66580

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

6433102

Unique identification number in the NCBI database of chemical substances.

INN ID

8286

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CS(=O)(Nc1c2c(CN(CC2)c3nc4c(c(n3)N)c(c(c(c4)OC)OC)-c5ncccc5)ccc1)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Taprizosin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.